Pedro Gonzalez Amaro
General Practice · Homestead, FLNPI 1558613000
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by AstraZeneca at 50.9% of the total. 2025 is the largest year on record at $271, more than ten times the $16 reported in 2021.
Across 13 payments — averaging $29.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$194
- Sumitomo Pharma America, Inc.$95
- Lilly USA, LLC$39
- Novartis$20
- Johnson & Johnson$18
- Kowa Pharmaceuticals America, Inc.$16
Across 6 payments — averaging $162,652 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$976K
What the payments were for
- Food & beverage$381100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 4 | $194 |
| Sumitomo Pharma America, Inc. | 4 | $95 |
| Lilly USA, LLC | 2 | $39 |
| Novartis | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$122
How this compares
$381 in reported general payments places this provider in the 60th percentile of 6,901 general practice providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 80 | $63,603 |
| FarxigaDapagliflozin Propanediol | 71 | $63,206 |
| EliquisApixaban | 70 | $49,622 |
| OzempicSemaglutide | 35 | $40,870 |
| JardianceEmpagliflozin | 54 | $37,669 |
| EntrestoSacubitril/Valsartan | 25 | $23,016 |
| LinzessLinaclotide | 28 | $20,730 |
| TradjentaLinagliptin | 19 | $19,785 |
| XareltoRivaroxaban | 25 | $19,651 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $16,724 |
| MyrbetriqMirabegron | 21 | $14,413 |
| JanumetSitagliptin Phos/Metformin Hcl | 19 | $10,649 |
| Diclofenac Sodium | 166 | $9,953 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 102 | $8,503 |
| VascepaIcosapent Ethyl | 13 | $6,864 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Symbicort | $194 | $66,40885 claims |
| NovartisEntresto | $20 | $23,01625 claims |
| Johnson & JohnsonXarelto | $18 | $19,65125 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 6,901 general practice providers in Florida.
Other general practice in Homestead
- Robert VogelPalm Beach Gardens$1M
- Bruce OuelletteWest Palm Beach$724K
- Caley CasteleinMiami Beach$586K
- Sarah JockinTampa$308K
- Mario RomeroSarasota$275K
- Robert RitterJupiter$233K
- Robert AltharPensacola$231K
- Florencia ZiemkeWest Palm Beach$208K
- Ausberto HidalgoPembroke Pines$171K
- Rickie FergusonPembroke Pines$170K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.